FDA Inspection
ReproTech, LLC.ReproTech, LLC. – FDA Inspection, Mar 6, 2019
Record Details
This FDA Inspection record concerns ReproTech, LLC., with an inspection on March 6, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 64a4e390-3acf-42cf-9a52-72646c253687
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1082797
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of ReproTech, LLC.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 4, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 4, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for ReproTech, LLC.
- FDA Inspection 1228932 - 2024-02-08
- FDA Inspection 987795 - 2016-05-04
- FDA Inspection 889756 - 2014-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.